Blood pressure can be seriously elevated during botulinum toxin A detrusor injection - Takeaways - MDSpire

Blood pressure can be seriously elevated during botulinum toxin A detrusor injection

  • By

  • Heinrich Schulte-Baukloh

  • Catarina Weiss

  • Burkert Pieske

  • Thorsten Schlomm

  • Bernhard Ralla

  • Hendrik Borgmann

  • Dirk Höppner

  • Sarah Weinberger

  • April 3, 2025

  • 0 min

Share

  • 1

    Onabotulinumtoxin A detrusor injection is used for overactive bladder after conservative therapies fail.

  • 2

    Real-world data on the efficacy and safety of OnabotA treatment for OAB is limited, despite promising clinical trial results.

  • 3

    Elevated blood pressure and heart rate were monitored during OnabotA injections to assess cardiovascular risk.

  • 4

    Patients with resting blood pressure above 190 mmHg were excluded from OnabotA injections and referred for cardiology evaluation.

  • 5

    The study included 70 female patients, primarily with idiopathic OAB, to evaluate hemodynamic changes during the procedure.

Original Source(s)

Blood pressure can be seriously elevated during botulinum toxin A detrusor injection

  • by Heinrich Schulte-Baukloh, Catarina Weiss, Burkert Pieske, Thorsten Schlomm, Bernhard Ralla, Hendrik Borgmann, Dirk Höppner, Sarah Weinberger

  • April 3, 2025

Related Content

Clinical parameters-based machine learning models for predicting intraoperative hemodynamic instability in hypertensive pheochromocytomas and paragangliomas patients

Identifying risk factors for vasculogenic etiology in patients with erectile dysfunction based on clinical features and machine learning

International Kidney Cancer Collaboration with Leadership from Philadelphia

Kidney cancer is a growing global health problem, and both clinicians and policymakers need to prepare for a steep rise in the number of cases,” said Alexander Kutikov, MD, FACS, Chair of the Department of Urology at Fox Chase Cancer Center, and senior author of a landmark international study published in European Urology, which demonstrates that if current trends continue, kidney cancer cases could double by 2050

  • by

  • December 2, 2025

  • 3 min